Skip to content
Subscriber Only

Wall Street Expects a Covid-19 Vaccine Before the U.S. Election

Inside A Moderna Therapeutics Lab As $5 Billion Startup Made Cancer Vaccine For One

Photographer: Adam Glanzman/Bloomberg

Wall Street predicts the White House will push through approval of one or maybe even two Covid-19 vaccines to help bolster Donald Trump’s chances before the U.S. presidential election.

While scientists, including the nation’s top virus expert Anthony Fauci, have set their eyes on a vaccine by early 2021 at the earliest, sell-side research analysts have been bringing in experts to weigh in on the possibility of a shorter timeline -- ahead of the Nov. 3 vote.